Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 101.72B | 101.43B | 99.94B | 93.85B | 80.79B | 86.96B |
Gross Profit | 15.59B | 15.68B | 15.65B | 15.27B | 14.36B | 10.86B |
EBITDA | 7.50B | 10.47B | 9.17B | 8.24B | 8.08B | 5.22B |
Net Income | 588.00M | 2.16B | 1.11B | -1.68B | 1.32B | -125.00M |
Balance Sheet | ||||||
Total Assets | 118.11B | 109.95B | 111.54B | 100.11B | 96.92B | 93.89B |
Cash, Cash Equivalents and Short-Term Investments | 4.14B | 1.76B | 3.11B | 3.71B | 5.06B | 4.25B |
Total Debt | 48.43B | 41.15B | 39.78B | 36.70B | 36.15B | 37.44B |
Total Liabilities | 79.72B | 71.11B | 70.94B | 67.91B | 65.00B | 65.50B |
Stockholders Equity | 37.45B | 37.93B | 39.72B | 31.43B | 31.06B | 27.56B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -3.45B | -3.14B | -1.26B | 1.72B | -3.65B |
Operating Cash Flow | 0.00 | 1.73B | 2.97B | 4.88B | 5.08B | 318.00M |
Investing Cash Flow | 0.00 | -3.13B | -5.05B | -5.44B | -2.37B | -2.88B |
Financing Cash Flow | 0.00 | -138.00M | 1.25B | -940.00M | -2.47B | 2.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥9.94B | 3.37 | 2.52% | 2.17% | 66.19% | ||
73 Outperform | ¥9.67B | 4.86 | 5.55% | 1.49% | 78.77% | ||
72 Outperform | ¥10.05B | 5.56 | 3.69% | -4.87% | -19.11% | ||
70 Outperform | ¥8.59B | 6.03 | 7.13% | 0.69% | 7.21% | ||
62 Neutral | $16.85B | 11.50 | -7.38% | 2.96% | 1.59% | -23.36% | |
56 Neutral | ¥8.31B | ― | 2.73% | -3.96% | -462.50% | ||
51 Neutral | ¥8.79B | ― | 3.25% | 24.16% | 93.49% |